Warner Bros. Discovery, Inc.
OXAZOLE COMPOUND AS MULTI-TARGETED INHIBITOR OF IRAK4 AND BTK

Last updated:

Abstract:

Provided are a class of multi-targeted inhibitors of IRAK4 and BTK, and the use thereof in preparing a drug for treating IRAK4- and BTK-related diseases. The present invention specifically relates to the compounds represented by formula (II), isomers thereof or pharmaceutically acceptable salts thereof. ##STR00001##

Status:
Application
Type:

Utility

Filling date:

10 Jul 2020

Issue date:

25 Aug 2022